top of page
![](https://static.wixstatic.com/media/39f166_bcb33633103948f7abd86974023d5247~mv2.jpg/v1/fill/w_147,h_28,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/39f166_bcb33633103948f7abd86974023d5247~mv2.jpg)
SLLIP
OFFICIAL TITLE: SPANISH LUNG LIQUID VS. INVASIVE BIOPSY PROGRAM EVALUATION.
![](https://static.wixstatic.com/media/39f166_efca9b2f0f574a99863e465b6a09722a~mv2.jpg/v1/fill/w_147,h_64,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/39f166_efca9b2f0f574a99863e465b6a09722a~mv2.jpg)
CLINICAL TRIAL DETAILS
TUMOR DERIVED CELL FREE DNA (CFDNA) IS INCREASINGLY USED IN THE CLINIC TO OBTAIN GENOTYPE INFORMATION ABOUT LUNG CANCER, BUT ITS CONCORDANCE WITH CONCURRENT TUMOR-DERIVED SEQUENCED DATA IS NOT KNOWN. THE PRIMARY OBJECTIVE OF THIS STUDY IS TO DEMONSTRATE THE NON-INFERIORITY OF CFDNA-BASED VERSUS TUMOR TISSUE-BASED GENOTYPING.
​
​
SLLIP AT CLINICALTRIALS.GOV
TUMOR TYPE
PHASE
NSCLC
Observational
182
7
Spain
N
SITES
COUNTRY
STATUS
Closing
BLOG ARTICLES RELATED
![home_fondo_you_barra.jpg](https://static.wixstatic.com/media/9472c1_b375ad03c9e143159c52db73966bf233~mv2.jpg/v1/fill/w_108,h_10,al_c,lg_1,q_80,usm_0.33_1.00_0.00,enc_auto/home_fondo_you_barra.jpg)
SCIENTIFIC IMPACT
![home_fondo_you_barra.jpg](https://static.wixstatic.com/media/9472c1_b375ad03c9e143159c52db73966bf233~mv2.jpg/v1/fill/w_67,h_6,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/home_fondo_you_barra.jpg)
AACR 2019 – DOWNLOAD THE POSTER
ESMO 2018 – DOWNLOAD THE POSTER
WCLC 2018 – DOWNLOAD THE POSTER
ESMO 2017 – DOWNLOAD THE POSTER
SLLIP SITES
![home_fondo_you_barra.jpg](https://static.wixstatic.com/media/9472c1_b375ad03c9e143159c52db73966bf233~mv2.jpg/v1/fill/w_108,h_10,al_c,lg_1,q_80,blur_3,enc_auto/home_fondo_you_barra.jpg)
SPAIN
Hospital Universitari Dexeus
SPAIN
Hospital Universitari Vall D'Hebron
SPAIN
Institut Català d' Oncologia L'Hospitalet (ICO)
SPAIN
Hospital Santa Creu i Sant Pau
SPAIN
Institut Català d' Oncologia Badalona (ICO)
SPAIN
Hospital Arnau de Vilanova de Valencia
SPAIN
Hospital del Mar
bottom of page